NCT07457177 2026-03-09Phaes â…¡ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTLBeijing Tongren HospitalPhase 2 Not yet recruiting40 enrolled
NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT07227584 2025-11-12ALL Backbone in AYAsDana-Farber Cancer InstitutePhase 2 Not yet recruiting67 enrolled